| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Carboprost trometamol |
Is a |
False |
Carboprost (substance) |
Inferred relationship |
Some |
|
| Product containing carboprost (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carboprost (substance) |
Inferred relationship |
Some |
1 |
| Carboprost adverse reaction (disorder) |
Causative agent (attribute) |
True |
Carboprost (substance) |
Inferred relationship |
Some |
1 |
| Allergy to carboprost |
Causative agent (attribute) |
False |
Carboprost (substance) |
Inferred relationship |
Some |
|
| carboprost 250 microgrammes/mL, ampoule de 1 mL de solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carboprost (substance) |
Inferred relationship |
Some |
|
| Allergy to carboprost |
Causative agent (attribute) |
True |
Carboprost (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely carboprost (as carboprost trometamol) 250 microgram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Carboprost (substance) |
Inferred relationship |
Some |
1 |
| Carboprost trometamol |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Carboprost (substance) |
Inferred relationship |
Some |
|
| Carboprost-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carboprost (substance) |
Inferred relationship |
Some |
1 |
| Product containing only carboprost (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carboprost (substance) |
Inferred relationship |
Some |
1 |
| Carboprost only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carboprost (substance) |
Inferred relationship |
Some |
1 |
| Carboprost (as carboprost trometamol) 250 microgram/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Carboprost (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely carboprost (as carboprost trometamol) 125 microgram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Carboprost (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]